Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03821337 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation (rTMS) as a Tool to Decrease Pain and Improve Functioning
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03821337: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT03821337 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03821337, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Despite the availability of opioid replacement therapies, many opioid use disordered Veterans are not able to remain abstinent. Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation technique with a consistent, rapidly expanding literature base reporting positive outcomes in substance using populations. This pilot application will investigate a novel multi-session rTMS paradigm to determine feasibility and tolerability of this intervention in opioid use disordered Veterans.
Interventions
- DEVICE Sham TMS
- DEVICE repetitive Trans Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03821337
The ClinicalTrials.gov registry entry for NCT03821337 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham TMS is the first listed.
NCT03821337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03821337 about?
NCT03821337 is a clinical study titled "Transcranial Magnetic Stimulation (rTMS) as a Tool to Decrease Pain and Improve Functioning". Despite the availability of opioid replacement therapies, many opioid use disordered Veterans are not able to remain abstinent. Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation technique with a consistent, rapidly expanding literature base reporting positive outc...
What is the current status of trial NCT03821337?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-10-11. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03821337?
The interventions under investigation include: Sham TMS (DEVICE), repetitive Trans Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03821337?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.